作者：
Cortes,J. [1]
;
Digumarti,R. [2]
;
Parikh,P.M. [3]
;
Wetzler,M. [4]
;
Lipton,J.H. [5]
;
Hochhaus,A. [6]
;
Craig,A.R. [7]
;
Benichou,A..-C. [8]
;
Nicolini,F.E. ;
Kantarjian,H.M.
作者单位：
Abteilung Hmatologie/Onkologie, Klinik für Innere Medizin II, Universit?tsklinikum Jena, Jena
[1]
Indian Cooperative Oncology Network, Mumbai, India
[2]
Formerly of ChemGenex Pharmaceuticals, An indirect wholly owned subsidiary of Teva Pharmaceuticals
[3]
Division of Leukemia, Roswell Park Cancer Institute, Buffalo, NY, United States
[4]
Medical Oncology, Nizam's Institute of Medical Sciences, Hyderabad, India
[5]
Department of Leukemia, UT MD Anderson Cancer Center, Houston, TX, United States
[6]
Chronic Myelogenous Leukemia Group, Department of Hematology/Medical Oncology, Princess Margaret
[7]
Hematologie Clinique, Centre Hospitalier Lyon Sud, Pierre Bénite, France
[8]
发布时间
2013-11-20
换一批
